1. Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London London UK j.fitzgibbon@qmul.ac.uk a.f.h.alseraihi@qmul.ac.uk
2. Specialist Integrated Haematological Malignancy Diagnostic Service (SIHMDS), Pathology, Royal London Hospital, Barts Health NHS Trust London UK
3. MTA-SE Lendulet Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University Budapest Hungary